Global Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI08249098

Publication Date:

August 13, 2024

Pages:

112

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Pharmaceutical R&D Outsourcing Services (CRO) market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淧harmaceutical R&D Outsourcing Services (CRO) Industry Forecast鈥� looks at past sales and reviews total world Pharmaceutical R&D Outsourcing Services (CRO) sales in 2022, providing a comprehensive analysis by region and market sector of projected Pharmaceutical R&D Outsourcing Services (CRO) sales for 2023 through 2029. With Pharmaceutical R&D Outsourcing Services (CRO) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical R&D Outsourcing Services (CRO) industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical R&D Outsourcing Services (CRO) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharmaceutical R&D Outsourcing Services (CRO) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Pharmaceutical R&D Outsourcing Services (CRO) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical R&D Outsourcing Services (CRO) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical R&D Outsourcing Services (CRO).
United States market for Pharmaceutical R&D Outsourcing Services (CRO) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Pharmaceutical R&D Outsourcing Services (CRO) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Pharmaceutical R&D Outsourcing Services (CRO) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Pharmaceutical R&D Outsourcing Services (CRO) players cover IQVIA HOLDINGS, ICON (incl. PRA Health), PPD(Pharmaceutical Product Development), Laboratory Corporation, Syneos Health, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical R&D Outsourcing Services (CRO) market by product type, application, key players and key regions and countries.
Segmentation by Type:
Chemical Drug Research And Development
Biological Drug Research And Development
Traditional Chinese Medicine Research And Development
Segmentation by Application:
Drug Discovery And Early Research
Preclinical Research
Clinical Trials
Post-麻豆原创ing Follow-Up
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Chemical Drug Research And Development
Biological Drug Research And Development
Traditional Chinese Medicine Research And Development
Segmentation by Application:
Drug Discovery And Early Research
Preclinical Research
Clinical Trials
Post-麻豆原创ing Follow-Up
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
IQVIA HOLDINGS
ICON (incl. PRA Health)
PPD(Pharmaceutical Product Development)
Laboratory Corporation
Syneos Health
Parexel
Covance
Charles River Laboratories
Wuxi AppTec
Pharmaron Inc.
Hangzhou Tigermed Consulting
IQVIA
Joinn Laboratories (China)

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Size 2019-2030
2.1.2 Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Pharmaceutical R&D Outsourcing Services (CRO) by Country/Region, 2019, 2023 & 2030
2.2 Pharmaceutical R&D Outsourcing Services (CRO) Segment by Type
2.2.1 Chemical Drug Research And Development
2.2.2 Biological Drug Research And Development
2.2.3 Traditional Chinese Medicine Research And Development
2.3 Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Size by Type
2.3.1 Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Pharmaceutical R&D Outsourcing Services (CRO) Segment by Application
2.4.1 Drug Discovery And Early Research
2.4.2 Preclinical Research
2.4.3 Clinical Trials
2.4.4 Post-麻豆原创ing Follow-Up
2.4.5 Other
2.5 Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Size by Application
2.5.1 Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Size by Player
3.1 Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue by Player (2019-2024)
3.1.2 Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue 麻豆原创 Share by Player (2019-2024)
3.2 Global Pharmaceutical R&D Outsourcing Services (CRO) Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pharmaceutical R&D Outsourcing Services (CRO) by Region
4.1 Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Size by Region (2019-2024)
4.2 Global Pharmaceutical R&D Outsourcing Services (CRO) Annual Revenue by Country/Region (2019-2024)
4.3 Americas Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Size Growth (2019-2024)
4.4 APAC Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Size Growth (2019-2024)
4.5 Europe Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Size Growth (2019-2024)
4.6 Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Size by Country (2019-2024)
5.2 Americas Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Size by Type (2019-2024)
5.3 Americas Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Size by Region (2019-2024)
6.2 APAC Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Size by Type (2019-2024)
6.3 APAC Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Size by Country (2019-2024)
7.2 Europe Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Size by Type (2019-2024)
7.3 Europe Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) by Region (2019-2024)
8.2 Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Forecast
10.1 Global Pharmaceutical R&D Outsourcing Services (CRO) Forecast by Region (2025-2030)
10.1.1 Global Pharmaceutical R&D Outsourcing Services (CRO) Forecast by Region (2025-2030)
10.1.2 Americas Pharmaceutical R&D Outsourcing Services (CRO) Forecast
10.1.3 APAC Pharmaceutical R&D Outsourcing Services (CRO) Forecast
10.1.4 Europe Pharmaceutical R&D Outsourcing Services (CRO) Forecast
10.1.5 Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Forecast
10.2 Americas Pharmaceutical R&D Outsourcing Services (CRO) Forecast by Country (2025-2030)
10.2.1 United States 麻豆原创 Pharmaceutical R&D Outsourcing Services (CRO) Forecast
10.2.2 Canada 麻豆原创 Pharmaceutical R&D Outsourcing Services (CRO) Forecast
10.2.3 Mexico 麻豆原创 Pharmaceutical R&D Outsourcing Services (CRO) Forecast
10.2.4 Brazil 麻豆原创 Pharmaceutical R&D Outsourcing Services (CRO) Forecast
10.3 APAC Pharmaceutical R&D Outsourcing Services (CRO) Forecast by Region (2025-2030)
10.3.1 China Pharmaceutical R&D Outsourcing Services (CRO) 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Pharmaceutical R&D Outsourcing Services (CRO) Forecast
10.3.3 Korea 麻豆原创 Pharmaceutical R&D Outsourcing Services (CRO) Forecast
10.3.4 Southeast Asia 麻豆原创 Pharmaceutical R&D Outsourcing Services (CRO) Forecast
10.3.5 India 麻豆原创 Pharmaceutical R&D Outsourcing Services (CRO) Forecast
10.3.6 Australia 麻豆原创 Pharmaceutical R&D Outsourcing Services (CRO) Forecast
10.4 Europe Pharmaceutical R&D Outsourcing Services (CRO) Forecast by Country (2025-2030)
10.4.1 Germany 麻豆原创 Pharmaceutical R&D Outsourcing Services (CRO) Forecast
10.4.2 France 麻豆原创 Pharmaceutical R&D Outsourcing Services (CRO) Forecast
10.4.3 UK 麻豆原创 Pharmaceutical R&D Outsourcing Services (CRO) Forecast
10.4.4 Italy 麻豆原创 Pharmaceutical R&D Outsourcing Services (CRO) Forecast
10.4.5 Russia 麻豆原创 Pharmaceutical R&D Outsourcing Services (CRO) Forecast
10.5 Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Forecast by Region (2025-2030)
10.5.1 Egypt 麻豆原创 Pharmaceutical R&D Outsourcing Services (CRO) Forecast
10.5.2 South Africa 麻豆原创 Pharmaceutical R&D Outsourcing Services (CRO) Forecast
10.5.3 Israel 麻豆原创 Pharmaceutical R&D Outsourcing Services (CRO) Forecast
10.5.4 Turkey 麻豆原创 Pharmaceutical R&D Outsourcing Services (CRO) Forecast
10.6 Global Pharmaceutical R&D Outsourcing Services (CRO) Forecast by Type (2025-2030)
10.7 Global Pharmaceutical R&D Outsourcing Services (CRO) Forecast by Application (2025-2030)
10.7.1 GCC Countries 麻豆原创 Pharmaceutical R&D Outsourcing Services (CRO) Forecast
11 Key Players Analysis
11.1 IQVIA HOLDINGS
11.1.1 IQVIA HOLDINGS Company Information
11.1.2 IQVIA HOLDINGS Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
11.1.3 IQVIA HOLDINGS Pharmaceutical R&D Outsourcing Services (CRO) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 IQVIA HOLDINGS Main Business Overview
11.1.5 IQVIA HOLDINGS Latest Developments
11.2 ICON (incl. PRA Health)
11.2.1 ICON (incl. PRA Health) Company Information
11.2.2 ICON (incl. PRA Health) Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
11.2.3 ICON (incl. PRA Health) Pharmaceutical R&D Outsourcing Services (CRO) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 ICON (incl. PRA Health) Main Business Overview
11.2.5 ICON (incl. PRA Health) Latest Developments
11.3 PPD(Pharmaceutical Product Development)
11.3.1 PPD(Pharmaceutical Product Development) Company Information
11.3.2 PPD(Pharmaceutical Product Development) Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
11.3.3 PPD(Pharmaceutical Product Development) Pharmaceutical R&D Outsourcing Services (CRO) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 PPD(Pharmaceutical Product Development) Main Business Overview
11.3.5 PPD(Pharmaceutical Product Development) Latest Developments
11.4 Laboratory Corporation
11.4.1 Laboratory Corporation Company Information
11.4.2 Laboratory Corporation Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
11.4.3 Laboratory Corporation Pharmaceutical R&D Outsourcing Services (CRO) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Laboratory Corporation Main Business Overview
11.4.5 Laboratory Corporation Latest Developments
11.5 Syneos Health
11.5.1 Syneos Health Company Information
11.5.2 Syneos Health Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
11.5.3 Syneos Health Pharmaceutical R&D Outsourcing Services (CRO) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Syneos Health Main Business Overview
11.5.5 Syneos Health Latest Developments
11.6 Parexel
11.6.1 Parexel Company Information
11.6.2 Parexel Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
11.6.3 Parexel Pharmaceutical R&D Outsourcing Services (CRO) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Parexel Main Business Overview
11.6.5 Parexel Latest Developments
11.7 Covance
11.7.1 Covance Company Information
11.7.2 Covance Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
11.7.3 Covance Pharmaceutical R&D Outsourcing Services (CRO) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Covance Main Business Overview
11.7.5 Covance Latest Developments
11.8 Charles River Laboratories
11.8.1 Charles River Laboratories Company Information
11.8.2 Charles River Laboratories Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
11.8.3 Charles River Laboratories Pharmaceutical R&D Outsourcing Services (CRO) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Charles River Laboratories Main Business Overview
11.8.5 Charles River Laboratories Latest Developments
11.9 Wuxi AppTec
11.9.1 Wuxi AppTec Company Information
11.9.2 Wuxi AppTec Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
11.9.3 Wuxi AppTec Pharmaceutical R&D Outsourcing Services (CRO) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Wuxi AppTec Main Business Overview
11.9.5 Wuxi AppTec Latest Developments
11.10 Pharmaron Inc.
11.10.1 Pharmaron Inc. Company Information
11.10.2 Pharmaron Inc. Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
11.10.3 Pharmaron Inc. Pharmaceutical R&D Outsourcing Services (CRO) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Pharmaron Inc. Main Business Overview
11.10.5 Pharmaron Inc. Latest Developments
11.11 Hangzhou Tigermed Consulting
11.11.1 Hangzhou Tigermed Consulting Company Information
11.11.2 Hangzhou Tigermed Consulting Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
11.11.3 Hangzhou Tigermed Consulting Pharmaceutical R&D Outsourcing Services (CRO) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Hangzhou Tigermed Consulting Main Business Overview
11.11.5 Hangzhou Tigermed Consulting Latest Developments
11.12 IQVIA
11.12.1 IQVIA Company Information
11.12.2 IQVIA Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
11.12.3 IQVIA Pharmaceutical R&D Outsourcing Services (CRO) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 IQVIA Main Business Overview
11.12.5 IQVIA Latest Developments
11.13 Joinn Laboratories (China)
11.13.1 Joinn Laboratories (China) Company Information
11.13.2 Joinn Laboratories (China) Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
11.13.3 Joinn Laboratories (China) Pharmaceutical R&D Outsourcing Services (CRO) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 Joinn Laboratories (China) Main Business Overview
11.13.5 Joinn Laboratories (China) Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.